REDW — Redwood Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK25.16m
- SEK24.34m
Brief: Redwood Pharma Rights Issue Significantly Oversubscribed
Brief: Redwood Pharma Q2 Operating Loss Narrows To SEK 4.3 Mln
Brief: Redwood Pharma Carries Out Rights Issue With Aim Of Replacing Existing Credit Facility
Brief: Redwood Pharma Updates Regarding Financial Situation
Brief: Redwood Pharma Jan-March Operating Loss Widens To SEK 3.3 Million
Brief: Redwood Pharma Q4 Operating Loss Narrows To Sek 3.0 Million
Brief: Redwood Pharma Receives Its Third And Last National Approval
Brief: Redwood Pharma Receives Approval From Another Drug Authority - The Austrian
Brief: Redwood Pharma July-Sept Operating Loss Sek 3.8 Million
Brief: Redwood Pharma Initiates Clinical Trial
Brief: Redwood Pharma: EPO Issued Prior Notice Of Granting New Patent
Brief: Redwood Pharma Q2 Operating Loss Widens To SEK 5.6 Million
Brief: Redwood Pharma Q1 Operating Loss Narrows To SEK 1.5 Million
Brief: Redwood Pharma New Issue Oversubscribed
Brief: Redwood Pharma Acquires Intellectual Property Rights
Brief: Redwood Pharma: Asian Pharmaceutical Firm To Evaluate IntelliGel
Brief: Redwood Pharma: Additional US patent to be granted regarding IntelliGel
Brief: Redwood Pharma Q4 Operating Loss Widens To SEK 5.3 Million
Brief: Redwood Pharma Q3 operating loss widens to SEK 5.2 mln